RU EN

Mon.-Fri.: 1000-1900

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

«A.Zalesov & Partners» Patent & Law Firm is a full-service IP law firm that gives IP advice, handles litigation (patents, trademarks and designs) and provides services in patent, design and trademark prosecution in the Russian Patent and Trademark Office and the Eurasian Patent Office. We handle our international clients' patent and trademark portfolios (including Madrid and Hague Systems of trademark and design registration) in Russia as well as in the neighboring countries, including the countries of the Eurasian Custom and Economic Union. Twenty years of experience in conducting patent and trademark disputes between leading players in the relevant markets in Russia and abroad enables us to give verified practical advice on IP protection, invalidation and enforcement strategy.

 

In focus

The Presidium of the Russian IP Court has confirmed the right to use inventions for the dapagliflozin compound and a pharmaceutical composition containing dapagliflozin

On March 10, 2026, the Presidium of the Russian IP Court considered the cassation appeals of the foreign entity AstraZeneca AB and AstraZeneca Pharmaceuticals LLC against the decision of the IP Court dated December 02, 2025, in case No. SIP-298/2025. Following the review, the cassation court upheld the decision of the court of first instance and dismissed the appeals.

16.03.2026

A.Zalesov & Partners wins: The court dismissed the client's claims in a case alleging patent infringement for certain grain dryer components

«A.Zalesov & Partners» team defended the client's interests in a case regarding the infringement of patents for three utility models, the recovery of compensation, and the prohibition of the products' introduction into civil circulation and the publication of the decision on the company's official website.

16.03.2026

The Constitutional Court of the Russian Federation ruled the provisions of paragraph 1 of Article 1362 of the Civil Code of the Russian Federation on compulsory licensing are in accordance with the Constitution

On March 12, 2026, the Constitutional Court of the Russian Federation issued Resolution No. 13-P on the case of verifying the constitutionality of the provisions of paragraph 1 of Article 1362 of the Civil Code of the Russian Federation in connection with the complaints of Sanofi Russia Joint Stock Company and Vertex Pharmaceuticals Incorporated.

16.03.2026